REVOLUTION MEDICINES, INC.

RVMD US76155X1000

🆔
Registration No.
5611600
💰
Capitalization
Mid-cap

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

🔗
Website
https://www.revmed.com
Annual Performance 1
2021 2022 2023 2024 2025
-34% -9% 25% 55% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
112
🙍
Insiders
9
Person Price Shares Total Published Completed
Cislini Jeff
SR OFF 		44.26
USD 		1,799
Sold 		79,624
USD 		24/09/2025 24/09/2025
Horn Margaret A
COO 		45.82
USD 		4,775
Sold 		218,814
USD 		16/09/2025 16/09/2025
Cislini Jeff
SR OFF 		45.82
USD 		1,869
Sold 		85,647
USD 		16/09/2025 16/09/2025
Anders Jack
CFO 		45.82
USD 		2,320
Sold 		106,314
USD 		16/09/2025 16/09/2025
Wei Lin
SR OFF 		45.82
USD 		2,160
Sold 		98,982
USD 		16/09/2025 16/09/2025
Kelsey Stephen Michael
O 		45.82
USD 		5,367
Sold 		245,942
USD 		16/09/2025 16/09/2025
Goldsmith Mark A
O 		45.82
USD 		13,411
Sold 		614,558
USD 		16/09/2025 16/09/2025
Kelsey Stephen Michael
O 		46.93
USD 		1,318
Sold 		61,854
USD 		11/09/2025 15/09/2025
Kelsey Stephen Michael
O 		45.92
USD 		23,682
Sold 		1,087,418
USD 		11/09/2025 15/09/2025
Kelsey Stephen Michael
O 		43.58
USD 		44,059
Sold 		1,919,963
USD 		11/09/2025 11/09/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include REVOLUTION MEDICINES, INC. to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-12% 4% 47% 65% 80% 0% 53%
Last 52W Low 52W High All-Time Low All-Time High β
44.41 31.13 60.60 14.54 60.60
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Schroeder Thilo 2 59,999,962.00 29,999,981.00 05/12/2024 05/12/2024
Kelsey Stephen Michael 32 14,033,598.38 438,549.95 18/12/2023 16/09/2025
Goldsmith Mark A 22 8,415,564.56 382,525.66 18/12/2023 16/09/2025
Horn Margaret A 14 4,921,236.13 351,516.87 06/12/2023 16/09/2025
Anders Jack 12 1,945,115.11 162,092.93 18/12/2023 16/09/2025
Cislini Jeff 22 1,837,204.24 83,509.28 20/11/2023 24/09/2025
Patel Sushil 3 445,269.50 148,423.17 10/04/2024 31/10/2024
Wei Lin 3 394,486.64 131,495.55 17/06/2024 16/09/2025
Weber Barbara 2 330,769.12 165,384.56 21/08/2024 08/10/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.